Browsing Tag

EscharEx

MediWound Receives Positive Scientific Advice from European Medicine Agency (EMA) on…

Eli Pacheco Jul 3, 2023 0

YAVNE, Israel, July 03, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue…

Health

MediWound Announces Peer-Reviewed Paper Detailing EscharEx Phase 2 Randomized Control…

Eli Pacheco Jul 11, 2021 0

Study Findings Demonstrate Strong Results in Debriding Venous Leg Ulcers and Diabetic Foot Ulcers Interim Assessment of Ongoing U.S. Phase II Adaptive Design Study in Venus Leg Ulcers…

Health

MediWound Completes Patient Enrollment for Interim Assessment of its U.S. EscharEx…

Eli Pacheco Jun 10, 2021 0

YAVNE, Israel, June 09, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue…